期刊文献+

李达以“血积”辨治原发性血小板增多症经验 被引量:6

LI Da's experience in differentiating and treating primary thrombocytosis based on'blood stagnation' theory
原文传递
导出
摘要 伴随着环境的日益恶化及社会的老龄化,原发性血小板增多症等慢性骨髓增殖性疾病的发病率呈逐年上升趋势,由于长期用药所带来的精神压抑严重影响患者生活质量,越来越引起临床医患的重视。中医药在本病治疗上有一定优势与特色,李达教授在长期临床实践中,探讨以"血积"概括病名,以瘀毒蕴结于髓为核心病机,总结出以益肾疏肝、活血解毒为主要治法,临证巧用虫类药、毒类药,配合体质辨识、因人制宜,并根据病情分层治疗本病,收效甚佳。 With the worsening of environment and the aging of society,the morbidity of chronic myeloproliferative diseases(CMPD) such as essential thrombocytosis(ET) showed an increasing tendency year by year.The psychology depression caused by long-term medication affected the life quality of patients seriously,which has drawn more and more attention of doctors and patients.Traditional Chinese medicine had advantages and characteristics in treating ET.In long-term clinical practice,professor LI Da named this disease as blood stagnation,summarized the principal pathogenesis of this disease as accumulation stasis toxin in bone marrow,and generalized the treatments for this disease as tonifying kidney and dispersing stagnated liver qi,promoting blood circulation and detoxication.He used insect drugs and poisonous drugs skillfully in clinic,and he was good at treating this disease based on the recognition of TCM constitution,individuality and patient's condition,and had achieved a very good curative effect.
作者 梁春灵 李达
出处 《中华中医药杂志》 CAS CSCD 北大核心 2016年第1期158-160,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 原发性血小板增多症 血积 李达 临证经验 Essential thrombocytosis Blood stagnation LI Da Clinical experience
  • 相关文献

参考文献3

二级参考文献15

共引文献99

同被引文献52

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部